Электронный научный журнал
European Student Scientific Journal
ISSN 2310-3094

ACTUAL PHARMACOLOGICAL BIOTECHNOLOGICAL INNOVATIONS TO IMPROVE THE QUALITY OF PATIENT’S LIFE THERAPEUTIC AND SURGICAL PROFILE

Karnaukh E.V. 1 Polikov G.O. 1 Zavgorodniy A.S. 1
1 The Kharkiv National Medical University
Modern effective drugs which are obtained by using biotechnological genetic engineering methods presented in this article. The main use in surgical and therapeutic clinical practice presents: modern recombinant probiotic generation V Subalin, which was synthesized by Ukrainian scientists for pharmacological treatment of intestinal dysbiosis, recombinant alpha-interferons Roferon-A (alfa-2a) and Altevir (alfa-2b).
Altevir
IFN
Roferon-А
Subalin
pharmaceuticals
genetic engineering
ACTUAL PHARMACOLOGICAL BIOTECHNOLOGICAL INNOVATIONS TO IMPROVE THE QUALITY OF PATIENT’S LIFE THERAPEUTIC AND SURGICAL PROFILE

Karnaukh E.V. 1 Polikov G.O. 1 Zavgorodniy A.S. 1
1 The Kharkiv National Medical University

Abstract:
Modern effective drugs which are obtained by using biotechnological genetic engineering methods presented in this article. The main use in surgical and therapeutic clinical practice presents: modern recombinant probiotic generation V Subalin, which was synthesized by Ukrainian scientists for pharmacological treatment of intestinal dysbiosis, recombinant alpha-interferons Roferon-A (alfa-2a) and Altevir (alfa-2b).

Keywords:
Altevir
IFN
Roferon-А
Subalin
pharmaceuticals
genetic engineering

Библиографическая ссылка

Karnaukh E.V., Polikov G.O., Zavgorodniy A.S. ACTUAL PHARMACOLOGICAL BIOTECHNOLOGICAL INNOVATIONS TO IMPROVE THE QUALITY OF PATIENT’S LIFE THERAPEUTIC AND SURGICAL PROFILE // European Student Scientific Journal. – 2016. – № 2.;
URL: http://sjes.esrae.ru/ru/article/view?id=376 (дата обращения: 22.07.2019).

Предлагаем вашему вниманию журналы, издающиеся в издательстве «Академия Естествознания»
(Высокий импакт-фактор РИНЦ, тематика журналов охватывает все научные направления)

«Фундаментальные исследования» список ВАК ИФ РИНЦ = 1.252